𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I-trial of clebopride, a new antiemetic, in chemotherapy — induced nausea and vomiting

✍ Scribed by H. J. Lenz; U. Schuler; W. Hicking; G. Ehninger

Publisher
Springer
Year
1990
Tongue
English
Weight
109 KB
Volume
38
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ondasetron versus granisetron in the pre
Ondasetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial
✍ Vittorio Gebbia; Giuseppe Cannata; Antonio Testa; Giuseppina Gurto; Roberto Vale 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Background. A single-institution, prospective, randomized open trial was performed to compare ondansetron and granisetron in the prevention of chemotherapyrelated nausea and vomiting. The effect of antemetic drugs was analyzed indipendently for patients treated with highly emetogenic chemotherapy (S

A phase I study of a new 5HT3-receptor a
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting
✍ Geoffrey Falkson; Adriaan J. Zyl 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 370 KB

In a phase I study of BRL43694A, a 5HT3-receptor antagonist, a single dose of 40 micrograms/kg was given to 24 patients. All patients received cytostatic treatment expected to cause nausea and vomiting. During the first 24 h, 12 patients were completely protected from nausea and vomiting, 4 experien